この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/8/161 分で読めます
National Eye Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Child Health and Human Development; Licensing Opportunity and/or Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Use of Antiflammins
ローカル自動翻訳 · 情報源の原言語
概要
The National Institutes of Health is seeking licensees and/or CRADA partners for the further development and commercialization of its patent portfolio for antiflammins. The inventions claimed in the following patent applications are available for either exclusive or non-exclusive licensing (in accordance with 35 U.S.C. 207 and 37 CFR Part 404) and/or further development under one or more CRADAs in several clinically important applications as described below in the Supplementary Information:
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →